The Effect of Xanthine Oxidase Inhibition Upon Ejection Fraction in Heart Failure Patients: La Plata Study
To access this article, please choose from the options below
Drs Cingolani and Brown are employees of Cardiome Pharma Corporation, Vancouver, BC, Canada, which sponsored the clinical trial.
PII: S1071-9164(06)00255-7
doi:10.1016/j.cardfail.2006.05.005
© 2006 Elsevier Inc. All rights reserved.
